Overview
This eCME focuses on the emerging role of antifibrotics in the management of progressive fibrotic interstitial lung diseases.
Faculty
Dr Raja Dhar
MBBS (Cal), MD (Respiratory Medicine), MRCP (UK) MSc (Evidence Based Medicine, UK) CCT (Respiratory and General Medicine UK), FCCP (USA), Diploma in Palliative Care (Newcastle University) Certificate in Education (Deeside University)
Director & HoD Pulmonology, Fortis Hospital. Director, Research & Education, National Allergy Asthma Bronchitis Institute, Kolkata, IndiaResources
External Resources
Progressive-Fibrosing ILD: How Our Management Approach is Changing
Also Read
Our Research
Our Research
